This study presents fair-market value (FMV) compensation rates by percentiles, with averages, for six (6) activities as well as for non-specific activities, for four (4) levels of Thought Leader influences (rare, international, national and local).
Payments made to physicians and thought leaders have been under scrutiny for a few years and companies have been working to adjust their rates to level with industry standards. Adjustments to “market” rates should be done periodically and are best done through 3rd party research, providing a fair and balanced assessment of rates.
The research findings deliver markets rates used in the conduct of exchanges with Thought Leaders from 30 life science organizations. These payment benchmarks help legal, compliance and medical affair executives refine and support the development of fee schedules that are aligned with market conditions.
1. Research Methodology
2. Definitions
- Therapeutic Area
- Thought Leader Levels
- Salary Data versus Market Rates
- Hourly Rates
- Flat Rates
3. Flat Rates
- Advisory Board Lead
- Advisory Board Non-lead
- Consulting Scientific / Clinical Content
- Consulting Commercial Content
- Speaking Scientific / Clinical Content
- Speaking Commercial Content
- Other Activities
4. Hourly Rates
- Advisory Board Lead
- Advisory Board Non-lead
- Consulting Scientific / Clinical Content
- Consulting Commercial Content
- Speaking Scientific / Clinical Content
- Speaking Commercial Content
- Other Activities
Analysts use primary and secondary research resources to develop our studies. The quantitative and qualitative data are collected through surveys and interviews conducted with professionals within the area of study. The data presented in our studies are an aggregate of survey and interview input. When possible, the data is presented by country. region or other factor to outline meaningful differences. We protect the identity and privacy of study participants and therefore blind their personal information and the organizations to which they belong - we only present the participation by company size and titles. This enables us to collect unbiased information, provided confidently by participants.
LOADING...
![Global Immunodiagnostic Market [By Technology - ELISA, CLIA & Rapid Test Reagent; By Application - Infectious Diseases, Oncology & Endocrinology, Hepatitis & Retrovirus and Cardiac Markers; By Products - Reagents, Instrumentation, Software & Services; By Region - Outlook 2025] - Product Image](http://d386vep05x5edh.cloudfront.net/product_images/8744/8744304_60px_jpg/global_immunodiagnostic_market_[by_technology_elisa_clia_and_rapid_test_reagent_by_application_infectious_diseases_oncology_and_endocrinology_hepatitis_and_retrovirus_and_cardiac_markers_by_products_reagents_instrumentation_software_and_services_by_region_outlook_2025].jpg)